We noticed you're blocking ads.

Keep supporting great journalism by turning off your ad blocker.

Questions about why you are seeing this? Contact us

Font Size

- Aa +

Mon 15 Aug 2016 01:58 PM

Font Size

- Aa +

UAE pharma firm Julphar posts $36.2m H1 net profit

Largest Emirati pharmaceutical company announces plans to launch Saudi operations in coming months

UAE pharma firm Julphar posts $36.2m H1 net profit

Julphar, the largest Emirati pharmaceutical company, has announced sales revenue of AED759.7 million in the first half of 2016.

The company said it posted a gross profit of AED465.7 million while its net profit for the period was AED133.8 million ($36.2 million).

Dr Ayman Sahli, CEO at Julphar said in comments published by news agency WAM: "We have accomplished significant progress. We have launched the real-time continuous glucose monitoring device (CGM), Dexcom G4 Platinum in Jordan, and as part of our commitment to contribute to a better healthcare in the region, we have launched new products in our targeted markets."

These include the general inhalational anesthetic Sojourn in Saudi Arabia, MEBO Scar in Algeria and the new Proton Pump Inhibitor Pantonix tablets in the UAE.

Sahli added: "Our divisions are also moving forward, as per Julphar’s ambition to drive for continuous improvement."

In June, Julphar Bangladesh has received the ISO certification from the Bangladesh Accreditation Board, demonstrating the company’s ability to provide medicines that meet and comply with international standards and regulatory requirements while Julphar Saudi Arabia’s operations are expected to launch in the coming months.

Arabian Business: why we're going behind a paywall

For all the latest health tips & news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.
Real news, real analysis and real insight have real value – especially at a time like this. Unlimited access ArabianBusiness.com can be unlocked for as little as $4.75 per month. Click here for more details.